• Je něco špatně v tomto záznamu ?

New laboratory markers in diagnosis of Alzheimer dementia

J. Mares, P. Kanovsky, R. Herzig, D. Stejskal, J. Vavrouskova, P. Hlustik, H. Vranova, S. Burval, J. Zapletalova, V. Pidrman, R. Obereigneru, A. Suchy, J. Vesely, J. Podivinsky, K. Urbanek

. 2009 ; 31 (10) : 1056-1059.

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12009114
E-zdroje Online

NLK Medline Complete (EBSCOhost) od 2005-01-01 do Před 1 rokem

OBJECTIVES: The aim of our work was to assess the role of tau protein, beta amyloid and cystatin C in diagnosis of Alzheimer dementia (AD) and other neurodegenerative diseases (NDs). METHODS: The levels of tau protein, beta amyloid and cystatin C were assessed in a set of 79 patients with ND (38 men and 41 women; aged 22-90 years; mean, 61.6 +/- 15.6 years) and in a control group of 79 subjects with a healthy central nervous system (38 men and 41 women; aged 20-91 years; mean, 61.5 +/- 15.1 years). RESULTS: When compared with the subjects in the control group, a statistically significant decrease in tau protein levels was found in patients with ND, an increase in tau protein levels in patients with AD and an increase in cystatin C cerebrospinal fluid/serum index in the ND + AD group. DISCUSSION: Our work only confirmed the previously reported results in part. Although tau protein seems to be a quite reliable marker of AD, the role of beta amyloid in AD diagnosis remains at the least questionable. In the case of cystatin C, our results would seem to confirm the views of certain authors that cystatin C will probably not become a new 'revolutionary' marker contributing to differential diagnostics.

000      
03454naa a2200661 a 4500
001      
bmc12009114
003      
CZ-PrNML
005      
20130114185623.0
008      
120319s2009 xxk eng||
009      
AR
040    __
$d ABA008 $a ABA008 $b cze
041    0_
$a eng
044    __
$a xxk
100    1_
$a Mareš, Jan $7 xx0060341 $u Department of Neurology, University Hospital, Olomouc, Czech Republic. maresja@seznam.cz
245    10
$a New laboratory markers in diagnosis of Alzheimer dementia $c J. Mares, P. Kanovsky, R. Herzig, D. Stejskal, J. Vavrouskova, P. Hlustik, H. Vranova, S. Burval, J. Zapletalova, V. Pidrman, R. Obereigneru, A. Suchy, J. Vesely, J. Podivinsky, K. Urbanek
520    9_
$a OBJECTIVES: The aim of our work was to assess the role of tau protein, beta amyloid and cystatin C in diagnosis of Alzheimer dementia (AD) and other neurodegenerative diseases (NDs). METHODS: The levels of tau protein, beta amyloid and cystatin C were assessed in a set of 79 patients with ND (38 men and 41 women; aged 22-90 years; mean, 61.6 +/- 15.6 years) and in a control group of 79 subjects with a healthy central nervous system (38 men and 41 women; aged 20-91 years; mean, 61.5 +/- 15.1 years). RESULTS: When compared with the subjects in the control group, a statistically significant decrease in tau protein levels was found in patients with ND, an increase in tau protein levels in patients with AD and an increase in cystatin C cerebrospinal fluid/serum index in the ND + AD group. DISCUSSION: Our work only confirmed the previously reported results in part. Although tau protein seems to be a quite reliable marker of AD, the role of beta amyloid in AD diagnosis remains at the least questionable. In the case of cystatin C, our results would seem to confirm the views of certain authors that cystatin C will probably not become a new 'revolutionary' marker contributing to differential diagnostics.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    02
$a senioři nad 80 let $7 D000369
650    02
$a stárnutí $x mok mozkomíšní $7 D000375
650    02
$a Alzheimerova nemoc $x diagnóza $x mok mozkomíšní $7 D000544
650    02
$a amyloidní beta-protein $x diagnostické užití $x mok mozkomíšní $7 D016229
650    02
$a biologické markery $x mok mozkomíšní $7 D015415
650    02
$a cystatin C $x diagnostické užití $x mok mozkomíšní $7 D055316
650    02
$a diferenciální diagnóza $7 D003937
650    02
$a ELISA $7 D004797
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a referenční hodnoty $7 D012016
650    02
$a neparametrická statistika $7 D018709
650    02
$a proteiny tau $x diagnostické užití $x mok mozkomíšní $7 D016875
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kaňovský, Petr, $d 1961- $7 jn20000620150
700    1_
$a Herzig, Roman, $d 1968- $7 mzk2007411122
700    1_
$a Stejskal, David $7 jx20111027043
700    1_
$a Vavroušková, Jitka. $7 xx0183964
700    1_
$a Hluštík, Petr, $d 1964- $7 xx0074066
700    1_
$a Vranová, Hana $7 xx0126244
700    1_
$a Buřval, Stanislav $7 xx0054189
700    1_
$a Zapletalová, Jana $7 xx0111614
700    1_
$a Pidrman, Vladimír, $d 1959- $7 nlk20000077032
700    1_
$a Obereignerů, Radko, $d 1978- $7 jo2004220518
700    1_
$a Suchý, Adam, $d 1974- $7 ola200206544
700    1_
$a Veselý, Jaroslav $7 jx20040617035
700    1_
$a Podivínský, Jiří $7 xx0104787
700    1_
$a Urbánek, Karel, $d 1937- $7 jn20000402457
773    0_
$t Neurological Research $p Neurol Res $g Roč. 31, č. 10 (2009), s. 1056-1059 $x def $w MED00008143
773    0_
$p Neurol Res $g 31(10):1056-9, 2009 Dec
910    __
$a ABA008 $b x $y 4
990    __
$a 20120319150907 $b ABA008
991    __
$a 20130114185745 $b ABA008
999    __
$a ok $b bmc $g 902338 $s 766020
BAS    __
$a 3
BMC    __
$a 2009 $b 31 $c 10 $d 1056-1059 $i def $m Neurological research $x MED00008143
LZP    __
$a 2012-1Q10/

Najít záznam

Citační ukazatele

Možnosti archivace